title: Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.
authors: Centers for Disease Control and Prevention, Atlanta, GA 30333, United States. bchen@cdc.gov
authors: Robert T
authors: RT
authors: Chen
authors: Dale J
authors: DJ
authors: Hu
authors: Eileen
authors: E
authors: Dunne
authors: Michael
authors: M
authors: Shaw
authors: James I
authors: JI
authors: Mullins
authors: Supachai
authors: S
authors: Rerks-Ngarm
mesh_terms: D016915:AIDS Vaccines / Q000191:economics / Q000276:immunology / Q000592:standards* / Q000600:supply & distribution; D002986:Clinical Trials as Topic; D003906:Developing Countries; D014644:Genetic Variation; D015488:HIV Antigens / Q000235:genetics / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology / Q000472:pathogenicity; D017325:Hepatitis B Vaccines / Q000191:economics / Q000276:immunology / Q000592:standards; D006801:Humans; D007252:Influenza Vaccines / Q000276:immunology / Q000592:standards; D008004:Licensure; D053918:Papillomavirus Vaccines / Q000191:economics / Q000276:immunology; D013785:Thailand; D014611:Vaccination
chemical_list: D016915:AIDS Vaccines; D015488:HIV Antigens; D017325:Hepatitis B Vaccines; D007252:Influenza Vaccines; D053918:Papillomavirus Vaccines